These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 8805943)
1. Purging of peripheral blood progenitor cells. Brugger W; Scheding S; Vogel W; Kanz L Ann Oncol; 1996; 7 Suppl 2():11-3. PubMed ID: 8805943 [No Abstract] [Full Text] [Related]
2. Ex-vivo purging of hematopoietic progenitor cells. de Lima M; Shpall EJ Curr Hematol Rep; 2004 Jul; 3(4):257-64. PubMed ID: 15217555 [TBL] [Abstract][Full Text] [Related]
3. Ex vivo purging and cell expansion. Ball ED J Hematother Stem Cell Res; 1999 Oct; 8(5):457-8. PubMed ID: 10791896 [No Abstract] [Full Text] [Related]
4. Purging of tumor cells from leukapheresis products: experimental and clinical aspects. Kvalheim G; Wang MY; Pharo A; Holte H; Jacobsen E; Beiske K; Kvaløy S; Smeland E; Funderud S; Fodstad O J Hematother; 1996 Aug; 5(4):427-36. PubMed ID: 8877718 [TBL] [Abstract][Full Text] [Related]
5. Ex vivo expansion of normal progenitor cells from acute myeloid leukemia cell-contaminated CD34+ peripheral blood progenitor cells after mafosfamide purging. Stilz R; Grünebach F; Bader P; Vogel W; Kanz L; Brugger W; Scheding S J Hematother Stem Cell Res; 2001 Dec; 10(6):777-85. PubMed ID: 11798504 [TBL] [Abstract][Full Text] [Related]
6. The impact of cytokines on high dose chemotherapy followed by transplantation of purified and ex vivo expanded peripheral blood stem cells: achieving a state of minimal residual disease for tumor immunotherapy with cytokine gene transfected cells. Mertelsmann R Eur Cytokine Netw; 1995; 6(2):79-82. PubMed ID: 7578991 [No Abstract] [Full Text] [Related]
7. Mononuclear and CD34+ stem cell recovery after automated Ficoll processing of marrow or peripheral blood stem cells for transplantation. Cottler-Fox M; Read EJ; Yu M; Carter C; Klein HG Prog Clin Biol Res; 1992; 377():569-73. PubMed ID: 1279726 [No Abstract] [Full Text] [Related]
8. Efficiency of in vivo purging with rituximab prior to autologous peripheral blood progenitor cell transplantation in B-cell non-Hodgkin's lymphoma: a single institution study. Belhadj K; Delfau-Larue MH; Elgnaoui T; Beaujean F; Beaumont JL; Pautas C; Gaillard I; Kirova Y; Allain A; Gaulard P; Farcet JP; Reyes F; Haioun C Ann Oncol; 2004 Mar; 15(3):504-10. PubMed ID: 14998857 [TBL] [Abstract][Full Text] [Related]
9. [Methods of mobilizing hematopoietic cells, their collection using cell separation, purging--processing of pathologic cells and enrichment with CD 34+ cells--negative and positive selection]. Walter Z; Szostek M; Mensah P; Lorenz F; Weglarska D; Skotnicki AB Przegl Lek; 1999; 56 Suppl 1():22-7. PubMed ID: 10494178 [TBL] [Abstract][Full Text] [Related]
10. The CD34 antigen: potential clinical advantages of CD34 selection. Holyoake TL; Alcorn MJ; Franklin IM Clin Oncol (R Coll Radiol); 1996; 8(4):214-21. PubMed ID: 8870998 [TBL] [Abstract][Full Text] [Related]
11. The role and methodology for purging tumor from autologous bone marrow and peripheral blood progenitor cells. Purdy MH; Shpall EJ Med Oncol; 1994; 11(2):47-51. PubMed ID: 7531586 [No Abstract] [Full Text] [Related]
12. Peripheral blood stem cells for autografting. Shpall EJ; Cagnoni PJ; Bearman SI; Ross M; Jones RB Annu Rev Med; 1997; 48():241-51. PubMed ID: 9046959 [TBL] [Abstract][Full Text] [Related]
13. Identification and positive selection of human progenitor/stem cells for bone marrow transplantation. Civin CI Prog Clin Biol Res; 1992; 377():461-72; discussion 473. PubMed ID: 1279715 [No Abstract] [Full Text] [Related]
14. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems. Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119 [TBL] [Abstract][Full Text] [Related]
15. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells . Haas R; Murea S Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679 [TBL] [Abstract][Full Text] [Related]
16. Autologous bone marrow support and bone disease in metastatic breast cancer. Nabholtz JM; al-Tweigeri T; Jacquelin N; Venner PM Can J Oncol; 1995 Jul; 5(2):369-75. PubMed ID: 8853509 [TBL] [Abstract][Full Text] [Related]